Skip to content

Multi-omics analysis revealed the molecular mechanism of abnormal trophoblast invasion in severe preeclampsia and placenta accreta

Multi-omics analysis revealed the molecular mechanism of abnormal trophoblast invasion in severe preeclampsia and placenta accreta

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108614
Enrollment
Unknown
Registered
2025-09-02
Start date
2025-09-06
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe preeclampsia, placenta accreta

Interventions

Placenta accreta group, normal pregnancy group:None
severe preeclampsia group:None

Sponsors

Zhengzhou Central Hospital affiliated to Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for preeclampsia and placenta accreta; 2. Gestational age>=18 years old; 3. Gestational age>=24 weeks; 4. Singleton pregnancy, natural conception, no obvious contractions before delivery, and the pregnancy outcome is cesarean section; 5. Pregnant women have no history of drug abuse, smoking or drinking; 6. Patients with preeclampsia are all early-onset preeclampsia, that is, the onset occurs before 34 weeks of pregnancy; Patients with placenta accreta all had complete placenta previa; 7. Each patient is informed of the use of the placenta and signs the informed consent form.

Exclusion criteria

Exclusion criteria: Those with one of the following conditions will be excluded: 1. History of primary chronic internal medicine, immune system, malignant tumors, and neuropsychiatric diseases such as hypertension, diabetes, heart disease, kidney disease, and systemic lupus erythematosus; 2. History of acute and chronic infectious diseases and pregnancy complications such as fetal chromosomal abnormalities or developmental malformations. 3. Exclude pregnancy complications such as premature rupture of membranes, polyhydramnios or too little amniotic fluid, and placental abruption; 4. Individuals conceived through assisted reproductive technology; 5. Twins and multiple births; 6. Gestational age< 18 years old; 7. Gestational age< 24 weeks.

Design outcomes

Primary

MeasureTime frame
transcriptome;proteome;

Secondary

MeasureTime frame
Metabolome;

Countries

China

Contacts

Public ContactZhang Fang

Zhengzhou Central Hospital affiliated to Zhengzhou University

yitianbian85@126.com+86 158 3801 9392

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026